SIRPA and colonic neoplasm: To investigate anti‐SIRPα mAb therapy‐induced inhibitory effects on sporadic colon cancer growth, we used a CDX2P9.5‐NLS Cre;APC+/FLOX (CPC‐APC) mouse model.